Results 61 to 70 of about 1,652,787 (364)

Prices of combination medicines and single‐molecule antihypertensive medicines in India's private health care sector

open access: yesThe Journal of Clinical Hypertension, 2021
More than half of patients with hypertension require two or more medicines to control blood pressure. Combinations of anti‐hypertensive medicines are available as Single Pill Combinations (SPCs) or Single Agent Pills (SAPs).
Sagri Negi   +7 more
doaj   +1 more source

Study of the advantages and risks of electronic retail trade in medicines

open access: yesФармацевтичний журнал, 2021
One of the most important issues of interest to scientists and practitioners of pharmacy is medicines quality assurance at all stages of their life cycle. From 2021 in Ukraine, the retail trade of medicines via the Internet was allowed.
O. O. Komarida   +4 more
doaj   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Knowledge, perception and practice of self-medication among premedical and basic science undergraduate medical students

open access: yesAsian Journal of Medical Sciences, 2016
Aims and Objective: Responsible self-medication is recognized as an important component of self-care. Medical students are in a unique position as they cannot yet legally prescribe medicines but their knowledge about and exposure to medicines increase as
P Ravi Shankar
doaj   +1 more source

Patient-centred pharmaceutical design to improve acceptability of medicines : similarities and differences in paediatric and geriatric populations [PDF]

open access: yes, 2014
Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are ...
Batchelor, Hannah K.   +7 more
core   +3 more sources

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Phenylpropanoids as a class of natural biologically active organo-protective compounds

open access: yesФармация и фармакология (Пятигорск)
The aim of the work was to analyze the current research state of phenylpropanoids as a special specific class of biologically active compounds and the prospects for their use for the development of medicines and biologically active food additives ...
V. A. Kurkin   +3 more
doaj   +1 more source

Mental health nurses’ medicines management role: a qualitative content analysis [PDF]

open access: yes, 2016
Aim: This study explores medicines management role undertaken by mental health nurses (MHN) in a wide variety of clinical specialisms and contexts. Method: Ten MHNs were interviewed and audiotaped.
Hemingway, Steve
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study

open access: yesFrontiers in Medicine, 2022
The European Medicines Agency provides Scientific Advice to medicines developers and patient input has been an integral part of this process for many years.
Aisling Murphy   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy